Pagină 1 din 20 rezultate
FIELD OF THE INVENTION
The present invention relates generally to the fields of cancer diagnosis, and particularly to methods for diagnosis of melanotic melanoma or metastatic melanotic melanoma. The use of texaphyrins for in vivo or in vitro detection of melanin or melanin metabolites diagnostic of
This invention relates to hormones for concentrating melanin in mammals and to methods of treating mammals using such hormones.
BACKGROUND OF THE INVENTION
A cyclic heptadecapeptide which induces melanosome aggregation within fish melanophores was isolated from salmon pituitary glands, see Kawauchi,
This invention relates to hormones for concentrating melanin in mammals and to methods of treating mammals using such hormones.
BACKGROUND OF THE INVENTION
A cyclic heptadecapeptide which induces melanosome aggregation within fish melanophores was isolated from salmon pituitary glands, see Kawauchi,
FIELD OF THE INVENTION
The present invention relates to the imaging and treatment of melanin-containing melanomas using radiolabeled anti-melanin antibodies, and to the imaging and treatment of tumors using radiolabled antibodies that bind to a cellular component released by dying tumor
FIELD OF THE INVENTION
The present invention relates to the generation of an Atomic Therapeutic Indicator (ATI) for a test sample by the quantification of manganese; in voxels of a 3D region of the sample, wherein the 3D region is topographically defined by co-ordinates X'.times.Y'.times.Z. The ATI
This application is a national stage application under 35 U.S.C. .sctn. 371 which claims priority of PCT Application No. PCT/CN2015/084494, filed Jul. 20, 2015.
FIELD OF THE INVENTION
The present invention substantially relates to the technical field of drugs, cosmetics, medical products,
FIELD OF THE INVENTION
The present invention relates to melanocyte stimulating hormones (MSH), in particular, melanotropin ligands having improved selectivity, stability, and bioavailability.
BACKGROUND OF THE INVENTION
There is a critical medical need for prevention of skin damage and development
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database